Utility of a molecular prescreening program in advanced colorectal cancer for enrollment on biomarker-selected clinical trials

M.J. Overman, V. Morris, B. Kee, D. Fogelman, L. Xiao, C. Eng, A. Dasari, R. Shroff, T. Mazard, K. Shaw, E. Vilar, K. Raghav, I. Shureiqi, L. Liang, G.B. Mills, R.A. Wolff, S. Hamilton, F. Meric-Bernstam, J. Abbruzzese, J. Morris, D. Maru, S. Kopetz

Open source

DOI
10.1093/annonc/mdw073
Published
2016-06
Container
Annals of Oncology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/annonc/mdw073,
  title = {Utility of a molecular prescreening program in advanced colorectal cancer for enrollment on biomarker-selected clinical trials},
  author = {M.J. Overman and V. Morris and B. Kee and D. Fogelman and L. Xiao and C. Eng and A. Dasari and R. Shroff and T. Mazard and K. Shaw and E. Vilar and K. Raghav and I. Shureiqi and L. Liang and G.B. Mills and R.A. Wolff and S. Hamilton and F. Meric-Bernstam and J. Abbruzzese and J. Morris and D. Maru and S. Kopetz},
  year = {2016},
  journal = {Annals of Oncology},
  doi = {10.1093/annonc/mdw073},
  url = {https://doi.org/10.1093/annonc/mdw073}
}

RIS

TY  - JOUR
TI  - Utility of a molecular prescreening program in advanced colorectal cancer for enrollment on biomarker-selected clinical trials
AU  - M.J. Overman
AU  - V. Morris
AU  - B. Kee
AU  - D. Fogelman
AU  - L. Xiao
AU  - C. Eng
AU  - A. Dasari
AU  - R. Shroff
AU  - T. Mazard
AU  - K. Shaw
AU  - E. Vilar
AU  - K. Raghav
AU  - I. Shureiqi
AU  - L. Liang
AU  - G.B. Mills
AU  - R.A. Wolff
AU  - S. Hamilton
AU  - F. Meric-Bernstam
AU  - J. Abbruzzese
AU  - J. Morris
AU  - D. Maru
AU  - S. Kopetz
PY  - 2016
JO  - Annals of Oncology
DO  - 10.1093/annonc/mdw073
UR  - https://doi.org/10.1093/annonc/mdw073
ER  - 

APA

Overman, M., Morris, V., Kee, B., Fogelman, D., Xiao, L., Eng, C., Dasari, A., Shroff, R., Mazard, T., Shaw, K., Vilar, E., Raghav, K., Shureiqi, I., Liang, L., Mills, G., Wolff, R., Hamilton, S., Meric-Bernstam, F., Abbruzzese, J., Morris, J., Maru, D., & Kopetz, S. (2016). Utility of a molecular prescreening program in advanced colorectal cancer for enrollment on biomarker-selected clinical trials. Annals of Oncology. https://doi.org/10.1093/annonc/mdw073

Source records